CoChat

The Use of Prescription Drugs, Recreational Drugs, and “Soft Enhancers” for Cognitive Enhancement among Swiss Secondary School Students

Open access
Liakoni, Evangelia, Schaub, Michael P., Maier, Larissa J., Glauser, Gaëlle-Vanessa, Liechti, Matthias E. · 2015 · PLOS ONE
Cited by 54

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The use of prescription or recreational drugs for cognitive enhancement (CE) is prevalent among students. However, the prevalence of CE among Swiss school students is unknown. We therefore performed a cross-sectional online survey including ≥ 16-year-old students from bridge-year schools (10th grade), vocational schools, and upper secondary schools (10th-12th grade) in the Canton of Zurich to investigate the prevalence of and motives for the use of prescription drugs, recreational drugs, and/or freely available soft enhancers for CE. A total of 1,139 students were included. Of these, 54.5% reported the use of prescription drugs (9.2%), recreational drugs including alcohol (6.2%), or soft enhancers (51.3%) explicitly for CE at least once in their lives. The last-year and last-month prevalence for CE considering all substances was 45.5% and 39.5%, respectively. Soft enhancers were the substances that were most commonly used (ever, last-year, and last-month, respectively), including energy drinks (33.3%, 28.4%, and 24.6%), coffee (29.8%, 25.1%, and 21.9%), and tobacco (12.6%, 9.3%, and 8.3%). CE with methylphenidate was less prevalent (4.0%, 2.8%, and 2.0%). However, the use of prescription drugs, alcohol, or illegal drugs for CE was reported by 13.3% of the participants. The most common motives for use were to stay awake and improve concentration. CE was more prevalent among students who reported higher levels of stress or performance pressure and students with psychiatric disorders. In conclusion, half of the school students had used a substance at least once in their lives to improve school performance. Soft enhancers were most commonly used. Prevalence rates were similar to those reported by Swiss university students, indicating that the use of prescription or recreational drugs for CE already occurs before starting higher education. Performance pressure, stress, and psychiatric disorders may be associated with CE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0141289

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 26

  1. LJ Maier, 2013, To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students, PLoS One, 8, e77967, 10.1371/journal.pone.0077967 · DOI · Paper page
  2. S Vrecko, 2013, Just how cognitive is "cognitive enhancement"? On the significance of emotions in university students' experiences with study drugs, AJOB Neurosci, 4, 4, 10.1080/21507740.2012.740141 · DOI · Paper page
  3. M Schermer, 2009, The future of psychopharmacological enhancements: expectations and policies, Neuroethics, 2, 75, 10.1007/s12152-009-9032-1 · DOI
  4. KJ Schelle, 2014, Attitudes toward pharmacological cognitive enhancement: a review, Front Syst Neurosci, 8, 53, 10.3389/fnsys.2014.00053 · DOI
  5. AM Arria, 2008, Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use, Pharmacotherapy, 28, 156, 10.1592/phco.28.2.156 · DOI · Paper page
  6. MJ Farah, 2014, Cognitive enhancement, WIREs Cogn Sci, 5, 95, 10.1002/wcs.1250 · DOI
  7. E Middendorff, 2012, Formen der Stresskompensation und Leistungssteigerung bei Studierenden. HISBUS-Befragung zur Verbreitung und zu Mustern von Hirndoping und Medikamentenmissbrauch, HIS: Forum Hochschule, 1
  8. LJ Maier, 2015, The use of prescription drugs and drugs of abuse for neuroenhancement in Europe: not widespread but a reality, Eur Psychologist
  9. D Repantis, 2010, Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review, Pharmacol Res, 62, 187, 10.1016/j.phrs.2010.04.002 · DOI · Paper page
  10. KS Bagot, 2014, Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review, Addiction, 109, 547, 10.1111/add.12460 · DOI · Paper page
  11. R Ott, 2014, Neuroenhancement among Swiss students: a comparison of users and non-users, Pharmacopsychiatry, 47, 22
  12. C Forlini, 2009, Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement, BMC Med Ethics, 10, 9, 10.1186/1472-6939-10-9 · DOI
  13. B Partridge, 2012, Public attitudes towards the acceptability of using drugs to treat depression and ADHD, Aust N Z J Psychiatry, 46, 958, 10.1177/0004867412450755 · DOI
  14. C Forlini, 2014, Knowledge, experiences and views of German university students toward neuroenhancement: an empirical-ethical analysis, Neuroethics
  15. B Partridge, 2012, A comparison of attitudes toward cognitive enhancement and legalized doping in sport in a community sample of Australian adults, Am J Bioethics Primary Res, 3, 81
  16. SE McCabe, 2009, Subtypes of nonmedical prescription drug misuse, Drug Alcohol Depend, 102, 63, 10.1016/j.drugalcdep.2009.01.007 · DOI · Paper page
  17. SE McCabe, 2005, Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey, Addiction, 100, 96, 10.1111/j.1360-0443.2005.00944.x · DOI · Paper page
  18. SE McCabe, 2011, Medical misuse of controlled medications among adolescents, Arch Pediatr Adolesc Med, 165, 729, 10.1001/archpediatrics.2011.114 · DOI · Paper page
  19. AG Franke, 2010, Pharmacological neuroenhancement and brain doping: chances and risks, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 53, 853
  20. AG Franke, 2011, Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students, Germany. Pharmacopsychiatry, 44, 60, 10.1055/s-0030-1268417 · DOI · Paper page
  21. S Mache, 2012, Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences, Wien Med Wochenschr, 162, 262, 10.1007/s10354-012-0115-y · DOI
  22. CI Ragan, 2013, What should we do about student use of cognitive enhancers? An analysis of current evidence, Neuropharmacology, 64, 588, 10.1016/j.neuropharm.2012.06.016 · DOI
  23. R de Jongh, 2008, Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories, Neurosci Biobehav Rev, 32, 760, 10.1016/j.neubiorev.2007.12.001 · DOI · Paper page
  24. LJ Maier, 2015, Pharmacological cognitive enhancement in healthy individuals: a compensation for cognitive deficits or a question of personality?, PLoS One, 10, e0129805, 10.1371/journal.pone.0129805 · DOI
  25. SP Novak, 2007, The nonmedical use of prescription ADHD medications: results from a national Internet panel, Subst Abuse Treat Prev Policy, 2, 32, 10.1186/1747-597X-2-32 · DOI · Paper page
  26. LA Kroutil, 2006, Nonmedical use of prescription stimulants in the United States, Drug Alcohol Depend, 84, 135, 10.1016/j.drugalcdep.2005.12.011 · DOI · Paper page

Cited by

Metadata

Authors
Liakoni, E., Schaub, M. P., Maier, L. J., Glauser, G.-V., & Liechti, M. E.
Venue
PLOS ONE
Published
2015-10-27
Volume
10
Issue
10
Pages
e0141289
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2339542115
Cited by
54
References
4
FWCI
3.87
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.